#BEGIN_DRUGCARD DB04229

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C18H33N5O8S2

# Chemical_IUPAC_Name:
2-[bis({2-[(carboxymethyl)({[(2-sulfanylethyl)carbamoyl]methyl})amino]ethyl})amino]acetic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
7,10,13-Tri(Carboxymethyl)-5,15-Dioxo-4,7,10,13,16-Pentaaza-1,19-Dithianonadecane

# HET_ID:
YMA

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C18H33N5O8S2/c24-14(19-1-7-32)9-22(12-17(28)29)5-3-21(11-16(26)27)4-6-23(13-18(30)31)10-15(25)20-2-8-33/h32-33H,1-13H2,(H,19,24)(H,20,25)(H,26,27)(H,28,29)(H,30,31)

# InChI_Key:
InChIKey=MRDWXQKAAKNXSP-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4229

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
511.613

# Molecular_Weight_Mono:
511.177054437

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1PY0

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.3

# Predicted_LogS:
-3.1

# Predicted_Water_Solubility:
3.91e-01 g/l

# Primary_Accession_No:
DB04229

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
5289611

# PubChem_Substance_ID:
46508339

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT03274

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC(=O)CN(CCN(CC(O)=O)CC(=O)NCCS)CCN(CC(O)=O)CC(=O)NCCS

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:07 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Periplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M18267

# Drug_Target_1_GenBank_ID_Protein:
141904

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
Not Available

# Drug_Target_1_Gene_Sequence:
>441 bp
ATGCGTAACATCGCGATCAAATTTGCTGCCGCAGGCATCCTCGCCATGCTGGCTGCCCCC
GCTCTTGCCGAAAATATCGAAGTTCATATGCTCAACAAGGGCGCCGAGGGCGCCATGGTT
TTCGAGCCTGCCTATATCAAGGCCAATCCCGGCGACACGGTCACCTTTATTCCGGTGGAC
AAAGGACATAATGTCGAATCCATCAAGGACATGATCCCTGAAGGCGCCGAAAAGTTCAAA
AGCAAGATCAACGAGAACTATGTGCTGACGGTTACCCAGCCCGGCGCATATCTGGTAAAG
TGCACACCGCATTATGCCATGGGTATGATCGCGCTCATCGCTGTCGGTGACAGCCCGGCC
AATCTCGACCAGATCGTTTCGGCCAAGAAGCCGAAGATTGTTCAGGAGCGGCTGGAAAAG
GTCATCGCCAGCGCCAAATAA

# Drug_Target_1_General_Function:
Energy production and conversion

# Drug_Target_1_General_References:
2824441	Yamamoto K, Uozumi T, Beppu T: The blue copper protein gene of Alcaligenes faecalis S-6 directs secretion of blue copper protein from Escherichia coli cells. J Bacteriol. 1987 Dec;169(12):5648-52.
2909547	Adman ET, Turley S, Bramson R, Petratos K, Banner D, Tsernoglou D, Beppu T, Watanabe H: A 2.0-A structure of the blue copper protein (cupredoxin) from Alcaligenes faecalis S-6. J Biol Chem. 1989 Jan 5;264(1):87-99.
3512305	Hormel S, Adman E, Walsh KA, Beppu T, Titani K: The amino acid sequence of the blue copper protein of Alcaligenes faecalis. FEBS Lett. 1986 Mar 3;197(1-2):301-4.
3595868	Petratos K, Banner DW, Beppu T, Wilson KS, Tsernoglou D: The crystal structure of pseudoazurin from Alcaligenes faecalis S-6 determined at 2.9 A resolution. FEBS Lett. 1987 Jun 29;218(2):209-14.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3558

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
15648

# Drug_Target_1_Name:
Pseudoazurin

# Drug_Target_1_Number_of_Residues:
146

# Drug_Target_1_PDB_ID:
3PAZ

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00127	Copper-bind

# Drug_Target_1_Protein_Sequence:
>Pseudoazurin precursor
MRNIAIKFAAAGILAMLAAPALAENIEVHMLNKGAEGAMVFEPAYIKANPGDTVTFIPVD
KGHNVESIKDMIPEGAEKFKSKINENYVLTVTQPGAYLVKCTPHYAMGMIALIAVGDSPA
NLDQIVSAKKPKIVQERLEKVIASAK

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
1-23

# Drug_Target_1_Specific_Function:
This soluble electron transfer copper protein is required for the inactivation of copper-containing nitrite reductase in the presence of oxygen. Serves as a direct electron donor to the nitrite reductase

# Drug_Target_1_SwissProt_ID:
P04377

# Drug_Target_1_SwissProt_Name:
AZUP_ALCFA

# Drug_Target_1_Synonyms:
Blue copper protein
Cupredoxin
Pseudoazurin precursor

# Drug_Target_1_Theoretical_pI:
8.45

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB04229
